Terms: = Lymphoma AND FAT1, CDHF7, 2195, ME5, hFat1, CDHR8
24 results:
1. Angioimmunoblastic T-cell lymphoma: Novel recurrent mutations and prognostic biomarkers by cell-free DNA profiling.
Zhang C; Mou B; Xu J; Wang J; Liu Q; Yang Y; Tang W; Zhong X; Xu C
Br J Haematol; 2023 Dec; 203(5):807-819. PubMed ID: 37646306
[TBL] [Abstract] [Full Text] [Related]
2. Characteristics of Molecular Genetic Mutations and Their Correlation with Prognosis in Adolescent and Adult Patients with Acute Lymphoblastic Leukemia.
Sun X; Liu X; Li Y; Shi X; Li Y; Tan R; Jiang Y; Sui X; Ge X; Xu H; Wang X; Fang X
Oncology; 2024; 102(1):85-98. PubMed ID: 37437551
[TBL] [Abstract] [Full Text] [Related]
3. Noninvasive genomic profiling of somatic mutations in oral cavity cancers.
Xi Y; Negrao MV; Akagi K; Xiao W; Jiang B; Warner SC; Dunn JD; Wang J; Symer DE; Gillison ML
Oral Oncol; 2023 May; 140():106372. PubMed ID: 37004423
[TBL] [Abstract] [Full Text] [Related]
4. Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma.
Tatarczuch M; Waltham M; Shortt J; Polekhina G; Hawkes EA; Ho SJ; Trotman J; Brasacchio D; Co M; Li J; Ramakrishnan V; Dunne K; Opat SS; Gregory GP
Blood Adv; 2023 Jul; 7(14):3531-3539. PubMed ID: 36947202
[TBL] [Abstract] [Full Text] [Related]
5. [Clinical features and prognosis of 166 cases of MYC/BCL2 double-expression diffuse large B-cell lymphoma].
Tang SH; Tian L; Zhao W; Wang J; Ke XY
Zhonghua Xue Ye Xue Za Zhi; 2022 Sep; 43(9):771-777. PubMed ID: 36709172
[No Abstract] [Full Text] [Related]
6. fat1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling.
Liebig S; Neumann M; Silva P; Ortiz-Tanchez J; Schulze V; Isaakidis K; Schlee C; Schroeder MP; Beder T; Morris LGT; Chan TA; Bastian L; Burmeister T; Schwartz S; Gökbuget N; Mochmann LH; Baldus CD
Sci Rep; 2023 Jan; 13(1):972. PubMed ID: 36653435
[TBL] [Abstract] [Full Text] [Related]
7. Case report: Chronic lymphocytic leukemia/small lymphocytic lymphoma and monomorphic epitheliotropic intestinal T-cell lymphoma: A composite lymphoma.
Zhang B; Zhang Y; Li Q; Jiang Q; Chu W; Gong H; Li R; Ji H
Pathol Oncol Res; 2022; 28():1610653. PubMed ID: 36567979
[No Abstract] [Full Text] [Related]
8. Detailed characterization of the transcriptome of single B cells in mantle cell lymphoma suggesting a potential use for SOX4.
Valentin Hansen S; Høy Hansen M; Cédile O; Møller MB; Haaber J; Abildgaard N; Guldborg Nyvold C
Sci Rep; 2021 Sep; 11(1):19092. PubMed ID: 34580376
[TBL] [Abstract] [Full Text] [Related]
9. Increased Toxicity Among Adolescents and Young Adults Compared with Children Hospitalized with Acute Lymphoblastic Leukemia at Children's Hospitals in the United States.
Gupta A; Damania RC; Talati R; O'Riordan MA; Matloub YH; Ahuja SP
J Adolesc Young Adult Oncol; 2021 Dec; 10(6):645-653. PubMed ID: 33512257
[No Abstract] [Full Text] [Related]
10. Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia.
Chang YH; Yu CH; Jou ST; Lin CY; Lin KH; Lu MY; Wu KH; Chang HH; Lin DT; Lin SW; Chen HY; Yang YL
Sci Rep; 2021 Jan; 11(1):769. PubMed ID: 33436855
[TBL] [Abstract] [Full Text] [Related]
11. Resource limited centres can deliver treatment for children with acute lymphoblastic leukaemia with risk-stratified minimal residual disease based UKALL 2003 protocol with no modification and a good outcome.
Lashkari HP; Faheem M; Sridevi Hanaganahalli B; Bhat KG; Joshi J; Kamath N; Ahlawat S; B P
Expert Rev Hematol; 2020 Oct; 13(10):1143-1151. PubMed ID: 32870048
[TBL] [Abstract] [Full Text] [Related]
12. Serum soluble VSIG4 as a surrogate marker for the diagnosis of lymphoma-associated hemophagocytic lymphohistiocytosis.
Yuan S; Wang Y; Luo H; Jiang Z; Qiao B; Jiang Y; Hu Y; Cheng Y; Chen X; Gong W; Huang Y; Zhao W; Luo D; Liu B; Su H; Zhou J; Song S
Br J Haematol; 2020 Apr; 189(1):72-83. PubMed ID: 31960419
[TBL] [Abstract] [Full Text] [Related]
13. Whole exome sequencing reveals mutations in fat1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified.
Laginestra MA; Cascione L; Motta G; Fuligni F; Agostinelli C; Rossi M; Sapienza MR; Righi S; Broccoli A; Indio V; Melle F; Tabanelli V; Calleri A; Novero D; Facchetti F; Inghirami G; Sabattini E; Bertoni F; Pileri SA
Mod Pathol; 2020 Feb; 33(2):179-187. PubMed ID: 31028364
[TBL] [Abstract] [Full Text] [Related]
14. [Spectrum of somatic mutations and their prognostic significance in adult patients with B cell acute lymphoblastic leukemia].
Feng J; Gong XY; Jia YJ; Liu KQ; Li Y; Dong XB; Fang QY; Ru K; Li QH; Wang HJ; Zhao XL; Jia YN; Song Y; Tian Z; Wang M; Tang KJ; Wang JX; Mi YC
Zhonghua Xue Ye Xue Za Zhi; 2018 Feb; 39(2):98-104. PubMed ID: 29562441
[No Abstract] [Full Text] [Related]
15. [Epidemiologic features of Philadelphia-negative chronic myeloproliferative disorders in Szabolcs-Szatmár-Bereg county, Hungary. Analysis of data of a 33-year period].
Jakó J; Szerafin L
Orv Hetil; 2017 Apr; 158(15):572-578. PubMed ID: 28393599
[TBL] [Abstract] [Full Text] [Related]
16. Spectrum of somatic mutations detected by targeted next-generation sequencing and their prognostic significance in adult patients with acute lymphoblastic leukemia.
Feng J; Li Y; Jia Y; Fang Q; Gong X; Dong X; Ru K; Li Q; Zhao X; Liu K; Wang M; Tian Z; Jia Y; Wang Y; Lin D; Wei H; Tang K; Mi Y; Wang J
J Hematol Oncol; 2017 Feb; 10(1):61. PubMed ID: 28245838
[TBL] [Abstract] [Full Text] [Related]
17. Systemic lupus erythematous and malignancy risk: a meta-analysis.
Cao L; Tong H; Xu G; Liu P; Meng H; Wang J; Zhao X; Tang Y; Jin J
PLoS One; 2015; 10(4):e0122964. PubMed ID: 25885411
[TBL] [Abstract] [Full Text] [Related]
18. Mutational spectrum of adult T-ALL.
Neumann M; Vosberg S; Schlee C; Heesch S; Schwartz S; Gökbuget N; Hoelzer D; Graf A; Krebs S; Bartram I; Blum H; Brüggemann M; Hecht J; Bohlander SK; Greif PA; Baldus CD
Oncotarget; 2015 Feb; 6(5):2754-66. PubMed ID: 25595890
[TBL] [Abstract] [Full Text] [Related]
19. Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations.
Neumann M; Heesch S; Schlee C; Schwartz S; Gökbuget N; Hoelzer D; Konstandin NP; Ksienzyk B; Vosberg S; Graf A; Krebs S; Blum H; Raff T; Brüggemann M; Hofmann WK; Hecht J; Bohlander SK; Greif PA; Baldus CD
Blood; 2013 Jun; 121(23):4749-52. PubMed ID: 23603912
[TBL] [Abstract] [Full Text] [Related]
20. fat1 cadherin provides a novel minimal residual disease marker in acute lymphoblastic leukemia.
Ardjmand A; de Bock CE; Shahrokhi S; Lincz LF; Boyd AW; Burns GF; Thorne RF
Hematology; 2013 Nov; 18(6):315-22. PubMed ID: 23433465
[TBL] [Abstract] [Full Text] [Related]
[Next]
